- Home
- IQV vs IP Comparison
IQV vs IP Comparison
Compare IQV & IP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- IP
- Stock Information
- Founded
- IQV 1982
- IP 1898
- Country
- IQV United States
- IP United States
- Employees
- IQV N/A
- IP N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- IP Paper
- Sector
- IQV Health Care
- IP Basic Materials
- Exchange
- IQV Nasdaq
- IP Nasdaq
- Market Cap
- IQV 31.6B
- IP 28.7B
- IPO Year
- IQV 2013
- IP N/A
- Fundamental
- Price
- IQV $150.19
- IP $47.35
- Analyst Decision
- IQV Buy
- IP Strong Buy
- Analyst Count
- IQV 20
- IP 9
- Target Price
- IQV $236.75
- IP $55.19
- AVG Volume (30 Days)
- IQV 2.4M
- IP 4.7M
- Earning Date
- IQV 05-06-2025
- IP 04-30-2025
- Dividend Yield
- IQV N/A
- IP 3.90%
- EPS Growth
- IQV 2.74
- IP 91.49
- EPS
- IQV 7.49
- IP 1.57
- Revenue
- IQV $15,405,000,000.00
- IP $18,619,000,000.00
- Revenue This Year
- IQV $4.08
- IP $49.92
- Revenue Next Year
- IQV $5.88
- IP $4.49
- P/E Ratio
- IQV $20.03
- IP $30.34
- Revenue Growth
- IQV 2.81
- IP N/A
- 52 Week Low
- IQV $135.97
- IP $33.16
- 52 Week High
- IQV $252.88
- IP $60.36
- Technical
- Relative Strength Index (RSI)
- IQV 40.77
- IP 44.65
- Support Level
- IQV $137.49
- IP $45.99
- Resistance Level
- IQV $154.17
- IP $48.33
- Average True Range (ATR)
- IQV 8.48
- IP 2.34
- MACD
- IQV 1.00
- IP 0.15
- Stochastic Oscillator
- IQV 58.37
- IP 64.05
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About IP International Paper Company
International Paper manufactures packaging products and cellulose fibers. It accounts for roughly one third of the North American corrugated packaging market. Though it has operations in Brazil, India, and China, more than three fourths of its sales come from North America. International Paper serves a variety of end markets, including industrial, consumer products, and manufacturing.